Dr Claire Roddie speaks to ecancer in an online interview for the virtual EHA 2020 meeting.
She discusses the idea of a low toxicity CAR T which is now being trialled for relapsed/refractory acute lymphoblastic leukaemia.
Dr Roddie gives a thorough account of how the manufacturing takes place and how treatment is given.
She gives some preliminary results and toxicities, which shows great promise.
Sign up to ecancer for free to receive tailored email alerts for more videos like this.